42 U.S.C. § 284f — Parkinson’s disease

submitted 82 years ago by Pub. L. 105-78 to r/title-42-THE-PUBLIC-HEALTH-AND-WELFARE · 566 words · no verdicts yet

in plain englishAI-generated · not legal advice

The Director of NIH must run a research and training program on Parkinson's disease, and coordinate it across NIH's institutes with a conference every two years. The Director can fund up to 10 "Morris K. Udall" research centers, each doing basic and clinical research for up to five years at a time. The Director can also give Udall Awards to top researchers for up to five years.

(a) In general. The Director of NIH must set up a program to conduct and support research and training on Parkinson's disease, limited by how much money Congress appropriates for this section. (b) Inter-institute coordination. (1) The Director must coordinate this program among every national research institute doing Parkinson's disease research. (2) That coordination must include a research-planning conference at least once every 2 years. Each conference must produce a report, sent to the Senate and House appropriations and health committees. (c) Morris K. Udall research centers. (1) The Director can award "Core Center Grants" to spark innovative, multidisciplinary Parkinson's research and training. The Director can fund up to 10 such grants, and each funded center is named a Morris K. Udall Center for Research on Parkinson's Disease. (2)(A) Each center must use one institution, or a group of cooperating institutions meeting the Director's requirements, and must do both basic and clinical research. (B) Each center may also: run training programs for scientists and health workers; provide ongoing education to health professionals; share information with the public; build a nationwide patient-data system, alone or with other centers; build a Parkinson's Disease Information Clearinghouse, alone or with other centers; and build a national education program on Parkinson's disease and patient care, alone or with other centers. (3) A center can use its grant money to pay stipends to trainees in its training programs. (4) Support for a center can last up to 5 years, and can be extended for more 5-year periods if a scientific peer-review group recommends the extension to the Director. (d) Morris K. Udall Awards. The Director can also create a grant program that supports individual researchers with a strong record in Parkinson's disease research, who show potential for major future breakthroughs in understanding, diagnosing, and treating the disease. These grants can run for up to 5 years.

the actual law source: uscode.house.gov ↗public domain

(a) In general

The Director of NIH shall establish a program for the conduct and support of research and training with respect to Parkinson’s disease (subject to the extent of amounts appropriated to carry out this section).

(b) Inter-institute coordination

(1) In general

The Director of NIH shall provide for the coordination of the program established under subsection (a) among all of the national research institutes conducting Parkinson’s disease research.

(2) Conference

Coordination under paragraph (1) shall include the convening of a research planning conference not less frequently than once every 2 years. Each such conference shall prepare and submit to the Committee on Appropriations and the Committee on Labor and Human Resources of the Senate and the Committee on Appropriations and the Committee on Commerce of the House of Representatives a report concerning the conference.

(1) In general

The Director of NIH is authorized to award Core Center Grants to encourage the development of innovative multidisciplinary research and provide training concerning Parkinson’s disease. The Director is authorized to award not more than 10 Core Center Grants and designate each center funded under such grants as a Morris K. Udall Center for Research on Parkinson’s Disease.

(2) Requirements

(A) In general

With respect to Parkinson’s disease, each center assisted under this subsection shall—

(i)

use the facilities of a single institution or a consortium of cooperating institutions, and meet such qualifications as may be prescribed by the Director of the NIH; and

(ii)

conduct basic and clinical research.

(B) Discretionary requirements

With respect to Parkinson’s disease, each center assisted under this subsection may—

(i)

conduct training programs for scientists and health professionals;

(ii)

conduct programs to provide information and continuing education to health professionals;

(iii)

conduct programs for the dissemination of information to the public;

(iv)

separately or in collaboration with other centers, establish a nationwide data system derived from patient populations with Parkinson’s disease, and where possible, comparing relevant data involving general populations;

(v)

separately or in collaboration with other centers, establish a Parkinson’s Disease Information Clearinghouse to facilitate and enhance knowledge and understanding of Parkinson’s disease; and

(vi)

separately or in collaboration with other centers, establish a national education program that fosters a national focus on Parkinson’s disease and the care of those with Parkinson’s disease.

(3) Stipends regarding training programs

A center may use funds provided under paragraph (1) to provide stipends for scientists and health professionals enrolled in training programs under paragraph (2)(B).

(4) Duration of support

Support of a center under this subsection may be for a period not exceeding five years. Such period may be extended by the Director of NIH for one or more additional periods of not more than five years if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director and if such group has recommended to the Director that such period should be extended.

(d) Morris K. Udall Awards for Excellence in Parkinson’s Disease Research

The Director of NIH is authorized to establish a grant program to support investigators with a proven record of excellence and innovation in Parkinson’s disease research and who demonstrate potential for significant future breakthroughs in the understanding of the pathogensis,1 diagnosis, and treatment of Parkinson’s disease. Grants under this subsection shall be available for a period of not to exceed 5 years.

Source credit: (July 1, 1944, ch. 373, title IV, § 409B, as added Pub. L. 105–78, title VI, § 603(c), Nov. 13, 1997, 111 Stat. 1520; amended Pub. L. 109–482, title I, § 103(b)(8), Jan. 15, 2007, 120 Stat. 3687.)

history & why it existsrecord from the source credit

1944Enacted · Pub. L. 105-78 · 111 Stat. 1520
2007Amended · Pub. L. 109-482 · 120 Stat. 3687

A history note hasn’t been published yet. The record shows enactment by Pub. L. 105-78 on 1944-07-01.

all 0 arguments · sorted by: best

no arguments yet — make the first case